Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression

Monocytes (CD14(+) cells) from advanced-stage hepatocellular carcinoma (HCC) patients express programmed death 1 ligand (PD-L)/PD-1 and suppress the host antitumor immune response. However, it is unclear whether cancer progression is associated with CD14(+) cells. We compared CD14(+) cell properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Asai, Akira, Yasuoka, Hidetaka, Matsui, Masahiro, Tsuchimoto, Yusuke, Fukunishi, Shinya, Higuchi, Kazuhide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465257/
https://www.ncbi.nlm.nih.gov/pubmed/32824016
http://dx.doi.org/10.3390/cancers12082286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465257/
https://www.ncbi.nlm.nih.gov/pubmed/32824016
http://dx.doi.org/10.3390/cancers12082286

Ejemplares similares